Michel Lagarde
CIK: 0001518973
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectStock Option (Right to Buy)
13.9K shares- - Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectStock Option (Right to Buy)
12.1K shares- - Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectRst. Stock Unit
5K shares- - Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectRst. Stock Unit
6.2K shares- - Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectStock Option (Right to Buy)
11.1K shares- - Sep 8, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)DirectRst. Stock Unit
3.6K shares- - May 1, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Award(A)DirectStock Option (Right to Buy)
2.9K shares- - Feb 28, 2026TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct360 shares at avg. $521.11$187K - Feb 28, 2026TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct837 shares at avg. $521.11$436K - Feb 25, 2026TMO
THERMO FISHER SCIENTIFIC INC.
Award(A)Direct2.2K shares- - Dec 4, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Exercise(M)Direct22K shares at avg. $132.66$2.9M - Dec 4, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Sale(S)Direct22K shares at avg. $563.56$12.4M - Dec 4, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Exercise(M)Direct18.6K shares at avg. $105.17$2.0M - Dec 3, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Sale(S)Direct2.5K shares at avg. $584.11$1.5M - Dec 3, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Sale(S)Direct29.5K shares at avg. $583.33$17.2M - Dec 3, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Exercise(M)Direct68K shares at avg. $105.17$7.2M - Dec 2, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Exercise(M)Direct36K shares at avg. $105.17$3.8M - Dec 2, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Sale(S)Direct30K shares at avg. $581.92$17.5M - Nov 13, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Sale(S)Direct4.6K shares at avg. $594.42$2.8M - Nov 13, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Exercise(M)Direct4.6K shares at avg. $253.99$1.2M - Aug 28, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct262 shares at avg. $489.74$128K - Aug 28, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct162 shares at avg. $489.74$79K - Aug 28, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct275 shares at avg. $489.74$135K - Aug 28, 2025TMO
THERMO FISHER SCIENTIFIC INC.
Tax Payment(F)Direct262 shares at avg. $489.74$128K - May 1, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
Award(A)DirectStock Option (Right to Buy)
2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Stock Option (Right to Buy) | 13,879 | - | - | Direct |
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Stock Option (Right to Buy) | 12,088 | - | - | Direct |
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Rst. Stock Unit | 4,950 | - | - | Direct |
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Rst. Stock Unit | 6,200 | - | - | Direct |
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Stock Option (Right to Buy) | 11,081 | - | - | Direct |
| Sep 8, 2026 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) Rst. Stock Unit | 3,600 | - | - | Direct |
| May 1, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award(A) Stock Option (Right to Buy) | 2,866 | - | - | Direct |
| Feb 28, 2026 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 360 | $521.11 | $187,456 | Direct |
| Feb 28, 2026 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 837 | $521.11 | $436,107 | Direct |
| Feb 25, 2026 | TMO THERMO FISHER SCIENTIFIC INC. | Award(A) | 2,231 | - | $0 | Direct |
| Dec 4, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Exercise(M) | 22,046 | $132.66 | $2,924,622 | Direct |
| Dec 4, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Sale(S) | 22,046 | $563.56 | $12,424,244 | Direct |
| Dec 4, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Exercise(M) | 18,637 | $105.17 | $1,960,053 | Direct |
| Dec 3, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Sale(S) | 2,521 | $584.11 | $1,472,541 | Direct |
| Dec 3, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Sale(S) | 29,479 | $583.33 | $17,195,985 | Direct |
| Dec 3, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Exercise(M) | 68,000 | $105.17 | $7,151,560 | Direct |
| Dec 2, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Exercise(M) | 36,000 | $105.17 | $3,786,120 | Direct |
| Dec 2, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Sale(S) | 30,000 | $581.92 | $17,457,600 | Direct |
| Nov 13, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Sale(S) | 4,638 | $594.42 | $2,756,920 | Direct |
| Nov 13, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Exercise(M) | 4,638 | $253.99 | $1,178,006 | Direct |
| Aug 28, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 262 | $489.74 | $128,340 | Direct |
| Aug 28, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 162 | $489.74 | $79,325 | Direct |
| Aug 28, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 275 | $489.74 | $134,734 | Direct |
| Aug 28, 2025 | TMO THERMO FISHER SCIENTIFIC INC. | Tax Payment(F) | 262 | $489.74 | $128,340 | Direct |
| May 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award(A) Stock Option (Right to Buy) | 2,398 | - | - | Direct |
1-25 of 29 transactions
About Lagarde Michel
Lagarde Michel (SEC CIK 0001518973) files insider reports with the SEC as President and CEO of WEST PHARMACEUTICAL SERVICES INC (WST), Director of VERTEX PHARMACEUTICALS INC / MA (VRTX) and Executive Vice President of THERMO FISHER SCIENTIFIC INC. (TMO).
Signal8 holds 12 ownership filings by Lagarde Michel (1 Form 3, 11 Form 4), filed between Feb 21, 2025 and Sep 10, 2026. Those filings report 29 transactions, from Feb 19, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lagarde Michel's filings is in EXTON, PA.
Recent filings by Lagarde Michel
- Sep 8, 2026: Grants or awards of WST derivative securities (6 lines, Form 4, code A).
- May 1, 2026: Grant or award of VRTX derivative securities (Form 4, code A).
- Feb 28, 2026: Tax withholdings of TMO shares (2 lines, Form 4, code F).
- Feb 25, 2026: Grant or award of TMO shares (Form 4, code A).
- Dec 4, 2025: Option exercise of TMO shares (Form 4, code M).
Other insiders filing for WEST PHARMACEUTICAL SERVICES INC (WST)
- HAUGEN JANET BRUTSCHEA, Director
- Favorite Annette F, Sr. VP & Chief HR Officer
- McMahon Robert W., SVP & Chief Financial Officer
- Campbell Shane Alden, SVP, Proprietary Segment
- Pucci Paolo, Director
- Michels Douglas A, Director